title: Aromatase inhibitors in premenopausal women: the need for proper contraceptive counseling.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Vandenput
authors.forename: Ignace
authors.initials: I
authors.lastname: Vergote
authors.forename: Frederic
authors.initials: F
authors.lastname: Amant
authors.forename: Patrick
authors.initials: P
authors.lastname: Neven
authors.forename: Robert
authors.initials: R
authors.lastname: Paridaens
authors.forename: Marie-Rose
authors.initials: MR
authors.lastname: Christiaens
mesh_terms: D000032:Abortion, Therapeutic; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000494:pharmacology*; D047072:Aromatase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003267:Contraception / Q000379:methods; D003376:Counseling; D005260:Female; D006301:Health Services Needs and Demand; D006801:Humans; D015411:Mastectomy, Modified Radical; D020380:Needs Assessment; D010051:Ovarian Neoplasms / Q000556:secondary; D010053:Ovary / Q000187:drug effects*; D011247:Pregnancy; D017697:Premenopause
chemical_list: D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors